CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A new class of breast cancer drug that women can take after the standard five years of tamoxifen therapy saves lives as well as prevents the return of tumors, researchers from Canada reported on Tuesday. Femara, made by Swiss drugmaker Novartis, reduced the risk of death by 39% in women who took it, compared with women who took a placebo. It reduced the spread of cancer, called metastasis, by 4%, the researchers told a meeting of the American Society of Clinical Oncology in New Orleans. The findings add to the evidence that the drugs, called aromatase inhibitors, are a valuable extra weapon in the arsenal against breast cancer, which will affect 1.2 million people globally this year and kill 40,000 in the United States alone. For the study, Paul Goss, from Princess Margaret Hospital in Toronto, has been studying 5,100 women who took the standard treatment, tamoxifen, for five years. Tamoxifen cuts the risk of breast cancer in half and greatly reduces the risk that it will come back in women who have already had one bout with the disease. Goss and his colleagues reported last year that Femara, known generically as letrozole, reduced even further the risk that breast cancer would return in women who took it after taking tamoxifen. "We in fact did reduce internal metastases, which are inevitably fatal," Goss said in a telephone interview. "We also reduced the risk of dying. We have a survival advantage for women taking this drug." Among women taking Femara, 28 died of breast cancer during the study. Among women taking the placebo, 45 died. The women took the drug for a median of 2 1/2 years. Goss said the drug seemed safe, but there is a concern that Femara seems to increase the risk of the bone-thinning disease osteoporosis. "There is an apparent slight increase in bone loss," he said. "A slightly increased number of women developed osteoporosis during the trial. But there was no difference in fractures. At least we know about it, and it is easy to fix and prevent. There will be some women in whom cancer is such a low risk and whose risk of osteoporosis is so high that this drug might not be suitable." Aromatase inhibitors, including the existing medication Arimidex, made by AstraZeneca, work through a different mechanism from tamoxifen by reducing the effects of estrogen, a hormone that can fuel tumor growth. (Reuters)
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
After 20 years, and after tonight, Obama will no longer be the Democrats' top star
August 20 2024 12:28 PM
Trump ally Laura Loomer goes after Lindsey Graham: ‘We all know you’re gay’
September 13 2024 2:28 PM
Melania Trump cashed six-figure check to speak to gay Republicans at Mar-a-Lago
August 16 2024 5:57 PM
Latest Stories
Ohio Lt. Gov. Jon Husted to replace JD Vance in the U.S. Senate
January 17 2025 5:21 PM
Boxers NYC Bartenders Calendar: Buff boys bulging for a cause
January 17 2025 2:30 PM
Kara Swisher calls Mark Zuckerberg a 'small little creature with a shriveled soul'
January 17 2025 3:31 AM
Florida Gov. Ron DeSantis appoints Ashley Moody as Marco Rubio's replacement in the Senate
January 16 2025 6:17 PM
Durk Dehner steps down from Tom of Finland Foundation after Nazi controversy
January 16 2025 4:48 PM
Queer TikTok creators remain hopeful despite Supreme Court’s ruling upholding TikTok ban
January 17 2025 5:05 PM
Joe Biden declares that Equal Rights Amendment is ‘law of the land’ in new announcement
January 17 2025 2:05 PM
Health and Human Services takes stand against nonconsensual intersex surgeries
January 16 2025 7:59 PM
EDM revolution: Anyma's residency at Sphere in Vegas
January 16 2025 6:00 PM
Megyn Kelly rants about 'obese' lesbians when talking about L.A. fires
January 16 2025 3:35 PM
Gay Congresswoman Becca Balint: I'll show Trump I'm not intimidated
January 17 2025 7:34 PM
The anti-LGBTQ+ clergy who'll be praying at Donald Trump's inauguration
January 17 2025 6:55 PM
Will TikTok go dark? Will Trump enforce the ban? Here's what to know
January 17 2025 3:18 PM
Panic at the disco: A new novel examines the queer mid-life crisis in a uniquely beautiful way
January 17 2025 1:29 PM
Supreme Court upholds ban on TikTok, ruling against a freedom of speech argument
January 17 2025 10:34 AM
Arienne Childrey on becoming Ohio's first trans city council member
January 17 2025 6:00 AM
Full list of performers at Trump's 2025 inauguration
January 16 2025 6:57 PM